Adherence to pharmacologic management of hypertension

Canadian Journal of Public Health

Volumn 89, Issue 5, 1998, Pages

  Feldman, Ross ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; DRUG ADMINISTRATION; HOME MONITORING; HUMAN; HYPERTENSION; PATIENT ATTITUDE; PATIENT COMPLIANCE;

EID: 0031733420     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03404494     Document Type: Article

References (18)

1. Haynes RB. Improving patient compliance in the management of hypertension. In: Kaplan NM, Ram CV (Eds.), Individualized Therapy of Hypertension. New York: Marcel Dekker Inc., 1995:257-73.
2. Luscher TF, Vetter H, Siegenthaler W, Vetter W. Compliance in hypertension: facts and concepts. J Hypertension 1985:3:3-9.
3. Haynes RB, Taylor W, Sackett DL, et al. Can simple clinical measurements detect patient noncompliance? Hypertension 1980;2:757-64.
4. Logan AG, Achber C, Milne B, et al. Work-site treatment of hypertension by specially trained nurses. Lancet 1979;11:1175-78.
5. Morisky DE, Levine DM, Green LW, et al. Fiveyear blood pressure control and mortality following health education for hypertensive patients. Am J Public Health 1963:73:153-62.
6. Psaty BM, Koepsell TD, Wagner EH, et al. The relative risk of incident coronary heart disease associated with recently stopping the use of blockers. JAMA 1990;263:1653-57.
7. Meinikow J, Kiste C. Patient compliance and medical research: Issues in methodology. J Gen Int Med 1994;9:96-105.
8. Levine DM, Green LW, Deeds SG, et al. Health education for hypertensive patients. JAMA 1979:41:1700-3.
9. Muhlhauser L, Sawicki PT, Dicilurgeit U, et al. Evaluation of a structured treatment and teaching programme on hypertension in general practice. Clin &-Exper Hypertension 1993;15:125-42.
10. Webb PA. Effectiveness of patient education and psychological counselling in promoting compliance and control among hypertensive patients. J Fam Pract 1980;10:1047-55.
11. Berger BA, Stanton, AL, Feley BG, et al. The effectiveness of an educational program to teach pharmacists to counsel hypertensive patients and influence adherence. J Pharm Marketing and Manage 1990;:5:27-41.
12. Nessman DG, Carnahan JE, Nugent CA. Increasing compliance: Patient-operated hypertension groups. Arch Intern Med 1980:140:142730.
13. Johnson AL, Taylor DW, Sackett DL, et al. Selfrecording blood pressure in the management of hypertension. Can Med Assoc J 1978:119:103439.
14. Baird MG, Bentley-Taylor MM, Carruthers SG, et al. A study of efficacy, tolerance and compliance of once-daily versus twice-daily metoprolol (Betaloc) in hypertension. Betaloc Compliance Canadian Cooperative Study Group. Clin Invest Med 1984:7:95-102.
15. Becker LA, Glanz K, Sobel E, et al. A randomized trial of special packaging of antihypertensive medications. J Fam Pract 1986;22:357-61.
16. Haynes RB, Sackett DL, Gibson ES, et al. Improvement of medication compliance in uncontrolled hypertension. Lancet 1976;1:126568.
17. Sackett DL, Haynes RB, Gibson ES, et al. Randomized clinical trial strategies for improving medication compliance in primary hypertension. Lancet 1975,1:1205-7.
18. Woolf SH, Battista RN, Anderson GM, et al. Assessing the clinical effectiveness of preventive maneuvers: Analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations. J Clin Epidemiol 1990;43:891-905.